Literature DB >> 24751567

Cardiovascular pathophysiology in chronic kidney disease: opportunities to transition from disease to health.

Matthew I Tomey1, Jonathan A Winston2.   

Abstract

BACKGROUND: Chronic kidney disease (CKD) is common, and is associated with a high burden of cardiovascular disease. This cardiovascular risk is incompletely explained by traditional risk factors, calling attention to a need to better understand the pathways in CKD contributing to adverse cardiovascular outcomes.
FINDINGS: Pathophysiological derangements associated with CKD, including disordered sodium, potassium, and water homeostasis, renin-angiotensin-aldosterone and sympathetic activity, anemia, bone and mineral metabolism, uremia, and toxin accumulation may contribute directly to progression of cardiovascular disease and adverse outcomes.
CONCLUSION: Improving cardiovascular health in patients with CKD requires improved understanding of renocardiac pathophysiology. Ultimately, the most successful strategy may be prevention of incident CKD itself.
Copyright © 2014 Icahn School of Medicine at Mount Sinai. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cardiorenal syndrome; cardiovascular disease; chronic kidney disease; renocardiac syndrome

Mesh:

Substances:

Year:  2013        PMID: 24751567     DOI: 10.1016/j.aogh.2013.12.007

Source DB:  PubMed          Journal:  Ann Glob Health        ISSN: 2214-9996            Impact factor:   2.462


  12 in total

Review 1.  Cardiovascular Complications Associated with Multiple Myeloma Therapies: Incidence, Pathophysiology, and Management.

Authors:  Vivek G Patel; Robert F Cornell
Journal:  Curr Oncol Rep       Date:  2019-03-05       Impact factor: 5.075

Review 2.  [Prognosis and therapy of inflammatory rheumatic diseases : Impact of renal manifestations].

Authors:  M Zänker; C D Cohen; H D Rupprecht
Journal:  Z Rheumatol       Date:  2015-05       Impact factor: 1.372

3.  Exclusion of Patients With Kidney Disease From Cardiovascular Trials.

Authors:  Julie H Ishida; Kirsten L Johansen
Journal:  JAMA Intern Med       Date:  2016-01       Impact factor: 21.873

4.  Magnetic resonance elastography-derived stiffness of the kidneys and its correlation with water perfusion.

Authors:  Deep Gandhi; Prateek Kalra; Brian Raterman; Xiaokui Mo; Huiming Dong; Arunark Kolipaka
Journal:  NMR Biomed       Date:  2019-12-30       Impact factor: 4.044

5.  Incidence and Predictors of Cardiovascular Disease among Type 1 and Type 2 Diabetes Mellitus in a Tertiary Health Care Setting of Ethiopia: 8-Year Retrospective Follow-Up Study.

Authors:  Gebiso Roba Debele; Bilisumamulifna Tefera Kefeni; Shuma Gosha Kanfe; Tadesse Awoke Ayele; Haileab Fekadu Wolde; Melaku Kindie Yenit; Mohammedjud Hassen Ahmed
Journal:  Risk Manag Healthc Policy       Date:  2021-05-13

6.  Fibroblast growth factor 23 (FGF23) induces ventricular arrhythmias and prolongs QTc interval in mice in an FGF receptor 4-dependent manner.

Authors:  Jonah M Graves; Julian A Vallejo; Chelsea S Hamill; Derek Wang; Rohan Ahuja; Shaan Patel; Christian Faul; Michael J Wacker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-04-30       Impact factor: 5.125

7.  Understanding and Overcoming the Challenges Related to Cardiovascular Trials Involving Patients with Kidney Disease.

Authors:  Julie H Ishida; Cynthia Chauhan; Barbara Gillespie; Ken Gruchalla; Peter A McCullough; Susan Quella; Alain Romero; Patrick Rossignol; David C Wheeler; Meaghan A Malley; Melissa West; Charles A Herzog
Journal:  Clin J Am Soc Nephrol       Date:  2021-04-23       Impact factor: 10.614

8.  Prevalence of chronic kidney disease associated with cardiac and vascular complications in hypertensive patients: a multicenter, nation-wide study in Thailand.

Authors:  Rungroj Krittayaphong; Ram Rangsin; Bandit Thinkhamrop; Cameron Hurst; Suthee Rattanamongkolgul; Nintita Sripaiboonkij; Wipaporn Wangworatrakul
Journal:  BMC Nephrol       Date:  2017-04-03       Impact factor: 2.388

9.  Carotid Intima-Media Thickness: A Surrogate Marker for Cardiovascular Disease in Chronic Kidney Disease Patients.

Authors:  Olutoyin Morenike Lawal; Michael Olabode Balogun; Anthony Olubunmi Akintomide; Oluwagbemiga Oluwole Ayoola; Tuoyo Omasan Mene-Afejuku; Oluwadare Ogunlade; Oluyomi Oluseun Okunola; Adekunle Oyeyemi Lawal; Adewale Akinsola
Journal:  Clin Med Insights Cardiol       Date:  2019-06-21

10.  Effect of Modified Alkaline Supplementation on Syngenic Melanoma Growth in CB57/BL Mice.

Authors:  Tommaso Azzarito; Luana Lugini; Enrico Pierluigi Spugnini; Rossella Canese; Alessio Gugliotta; Stefano Fidanza; Stefano Fais
Journal:  PLoS One       Date:  2016-07-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.